If You Believe In Transformative AI Healthcare Stocks Then This Cycle Could Be Your Next Exposure

Simply Wall St.04-07

AI in healthcare sits at the crossroads of two powerful forces: the push for better diagnostics and treatment, and a world where inflation, energy shocks, and policy uncertainty keep pressure on costs...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2625498193?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","is_english":true,"pubTime":"2026-04-07 10:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2625498193","market":"nz","top_or_hot":-1,"title":"If You Believe In Transformative AI Healthcare Stocks Then This Cycle Could Be Your Next Exposure","media":"Simply Wall St.","content":"<div>\n<p>AI in healthcare sits at the crossroads of two powerful forces: the push for better diagnostics and treatment, and a world where inflation, energy shocks, and policy uncertainty keep pressure on costs...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-bmt/beamtree-holdings-shares/news/if-you-believe-in-transformative-ai-healthcare-stocks-then-t\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If You Believe In Transformative AI Healthcare Stocks Then This Cycle Could Be Your Next Exposure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf You Believe In Transformative AI Healthcare Stocks Then This Cycle Could Be Your Next Exposure\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-07 10:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-bmt/beamtree-holdings-shares/news/if-you-believe-in-transformative-ai-healthcare-stocks-then-t><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AI in healthcare sits at the crossroads of two powerful forces: the push for better diagnostics and treatment, and a world where inflation, energy shocks, and policy uncertainty keep pressure on costs...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-bmt/beamtree-holdings-shares/news/if-you-believe-in-transformative-ai-healthcare-stocks-then-t\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-bmt/beamtree-holdings-shares/news/if-you-believe-in-transformative-ai-healthcare-stocks-then-t","article_id":"2625498193","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-bmt/beamtree-holdings-shares/news/if-you-believe-in-transformative-ai-healthcare-stocks-then-t","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2625498193","pubTimestamp":1775528357,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"AI in healthcare sits at the crossroads of two powerful forces: the push for better diagnostics and treatment, and a world where inflation, energy shocks, and policy uncertainty keep pressure on costs and access. While central banks, bond markets, and geopolitics keep volatility elevated, AI tools that improve accuracy, reduce waste, and speed up research can look attractive to investors seeking structural growth themes rather than short term macro calls. This article highlights three stocks...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","AGIX":"通用人工智能 ETF-AGIX","XLV":"健康照护类股ETF-SPDR","VGT":"信息技术ETF-Vanguard","BK4543":"AI","BK4587":"ChatGPT概念","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4528":"SaaS概念","LABU":"三倍做多标普生物-Direxion","AI":"C3.ai, Inc.","IME.AU":"IMEXHS LTD","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BMT.AU":"BEAMTREE HOLDINGS LTD","ARTY":"ISHARES FUTURE AI & TECH ETF","BK7094":"医疗保健技术","BK4588":"碎股","AIYY":"YIELDMAX AI OPTION INCOME STRATEGY ETF","AIPO":"Defiance AI and Power Infrastructure ETF","BK4551":"寇图资本持仓","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK4137":"综合支持服务","AYA.AU":"ARTRYA LTD","XBI":"SPDR S&P Biotech ETF","BK4023":"应用软件","HCSG":"Healthcare Svcs Group Inc","BK4581":"高盛持仓"},"translate_title":"如果您相信变革性人工智能医疗保健股票，那么这个周期可能是您的下一次投资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1.5,"BMT.AU":1,"AGIX":1.5,"AIYY":0.6,"XLV":1.5,"VGT":0.76,"AI":0.9,"LABU":0.6,"CHAT":1.5,"AIPO":1.5,"ARTY":1.5,"AYA.AU":1,"XBI":0.6,"IME.AU":1},"content_text":"AI in healthcare sits at the crossroads of two powerful forces: the push for better diagnostics and treatment, and a world where inflation, energy shocks, and policy uncertainty keep pressure on costs and access. While central banks, bond markets, and geopolitics keep volatility elevated, AI tools that improve accuracy, reduce waste, and speed up research can look attractive to investors seeking structural growth themes rather than short term macro calls. This article highlights three stocks from our Transformative AI Healthcare screener that embody that story, and shows how each one taps into this long term shift in medical care and efficiency. AdvertisementBeamtree Holdings (ASX:BMT) Overview: Beamtree Holdings provides AI based clinical coding, diagnostics decision support and data quality tools that help hospitals and labs automate routine tasks, improve data accuracy and support better patient care across Australia and overseas. Operations: Beamtree generates revenue mainly from Australia at about A$16.1 million, with additional contributions from Europe at around A$2.0 million and the rest of the world at roughly A$10.8 million. Market Cap: A$42.9 million Beamtree sits in the sweet spot of hospitals looking to cut costs and reduce errors through AI powered automation. It still operates at a size where a few large contracts can have a material impact. Its focus on autonomous coding, data quality and benchmarking tools provides exposure to the long term adoption of data driven healthcare. Analyst expectations of strong revenue and earnings growth reflect that potential. At the same time, the company is loss making, relies on external borrowing and has major international projects that have already been delayed, so execution on pipeline conversion and funding discipline will be crucial for investors watching this story unfold. AI automation combined with delayed international projects can create a tension between potential and execution for Beamtree. Get the full picture in the analyst forecasts for Beamtree Holdings to see what might tip the balance next. ASX:BMT Earnings & Revenue Growth as at Apr 2026 ImExHS (ASX:IME) Overview: ImExHS provides cloud based medical imaging software and outsourced radiology services, using its AQUILA, ALULA and ANTEROS platforms to help hospitals and clinics manage radiology, pathology and cardiology images and reports across multiple countries. Operations: ImExHS generates about A$10.0 million from Software and A$19.2 million from Radiology, with a small intersegment offset of A$0.2 million, and reports total revenue of roughly A$29.0 million largely from Latin America. Market Cap: A$21.1 million ImExHS sits at the intersection of cloud software and radiology services, with ARR of A$34.8 million, a multi tenant Aquila+ platform and 27 partners across 12 countries, supporting hospitals that want imaging systems and AI tools without building everything in house. Analysts expect faster revenue and earnings growth than the broader Australian market and Healthcare Services industry. At the same time, the company reports a loss of A$2.88 million and carries high funding risk, including an auditor flagged going concern caveat. For investors, that mix of recurring software revenue, Latin American exposure and balance sheet pressure raises sharp questions about how the story plays out next. Recurring software revenue and a cloud first model can be easy to focus on, while the real story sits in how funding pressure and losses interact with future expectations in the analyst forecasts for ImExHS ASX:IME Earnings & Revenue Growth as at Apr 2026 Artrya (ASX:AYA) Overview: Artrya is a medical technology company that uses artificial intelligence to read coronary CT angiography scans, helping clinicians detect and manage coronary artery disease and patients at risk of heart attack through its cloud based Salix software suite. Operations: Artrya currently reports A$0.03 million in revenue from the development of its AI driven CCTA image analysis technology in Australia. Market Cap: A$494.80 million Artrya gives you exposure to AI based cardiac imaging at an early commercial stage, where revenue is still very small but backed by a large CCTA scan opportunity, expanding reimbursement support for plaque assessment and a US study targeting up to 12,000 scans across major health systems. Analysts expect very strong revenue and earnings growth, yet the company is loss making, heavily funded by external capital and has seen shareholder dilution and rising losses, which keeps execution risk high. With recent index inclusions, new board and finance leadership and a sizeable cash position relative to current sales, the key question is how quickly trial results, product approvals and hospital adoption can close the gap between ambition and financial reality. Artrya’s early revenue and large imaging ambition can make the story feel incomplete, and the real swing factor sits in how expectations stack up against funding and execution in the analyst forecasts for Artrya ASX:AYA Earnings & Revenue Growth as at Apr 2026 The three stocks covered here are just a starting point, and the full Transformative Artificial intelligence (AI) Healthcare Stocks screener highlights 7 more companies with equally compelling AI healthcare stories that you have not seen yet. Use Simply Wall St to identify and analyze the exact catalysts that matter to you, from diagnostics accuracy to remote care and research efficiency, and filter the data and narratives into your highest conviction ideas. Take Control of Your Investment Journey  If Artrya or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your top picks to a Watchlist to monitor the share price against the fair value for the ideal entry point.\n            Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.\n            Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.\n            By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.\n         Curious About What Else You Might Be Missing Fresh ideas often move first. By the time momentum is strong, the most attractive entry points can be gone. Spot under the radar picks before the crowd and consider acting earlier in the cycle.  Chase steady compounding with companies that keep balance sheets tight and cash flows in check by reviewing the curated list of solid balance sheet and fundamentals (19 results) before others catch on. Ride longer term infrastructure shifts with businesses powering data centers and AI hardware by scanning the hand picked 36 AI infrastructure stocks while they are still under the radar. Position ahead of industrial and electrification themes by zeroing in on producers in the focused 8 top copper producer stocks before new demand stories begin drawing broader attention.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2625498193","isCrawlerRequest":true}